KeyBanc, Morgan Stanley Slash Price Target On Colfax


27% profits every 20 days?

This is what Nic Chahine averages with his options buys. Not selling covered calls or spreads... BUYING options. Most traders don't even have a winning percentage of 27% buying options. He has an 83% win rate. Here's how he does it.


  • Colfax Corp's (NYSE:CFXprice target has been lowered to $52 (an upside of 41%) from $60 by KeyBanc analyst Jeffrey Hammond, following ESAB/Enovis's 2022 Investor Day to reflect broadly lower peer multiples.
  • The analyst maintained an Overweight rating on CFX shares.
  • RelatedColfax's Q4 Earnings
  • Morgan Stanley also lowered its price target on Colfax to $41 (an upside of 11%) from $45 while maintaining the Equal-Weight ratings on the shares.
  • Colfax recently announced the future composition of the board of the company, which will be renamed Enovis Corp., upon the consummation of the company's previously announced spin-off of its existing fabrication technology business, which will operate as ESAB Corp.
  • Colfax revealed an expected completion date of April 4, 2022, for the spin-off of ESAB Corp.
  • Price Action: CFX shares are trading higher by 1.97% at $36.77 on the last check Tuesday.

27% profits every 20 days?

This is what Nic Chahine averages with his options buys. Not selling covered calls or spreads... BUYING options. Most traders don't even have a winning percentage of 27% buying options. He has an 83% win rate. Here's how he does it.


ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

Posted In: Analyst ColorNewsPrice TargetReiterationAnalyst RatingsMoversTrading IdeasBriefs